Published online before print January 4, 2007, doi: 10.1161/01.STR.0000254475.43533.dd
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2007;38:395.)
© 2007 American Heart Association, Inc.
Short Communication |
The Thr715Pro Polymorphism of the P-Selectin Gene Is Not Associated With Ischemic Stroke Risk
From Department of Neurology (J.F., W.L.), Hospital Barmherzige Brueder, Vienna, Austria; Clinical Institute of Medical and Chemical Laboratory Diagnostics (S.R., G.E., M.F., C.M.), Medical University Vienna, Vienna, Austria; University Clinic of Neurology (S.G., T.S., W.L.), Medical University Vienna, Austria.
Correspondence to Christine Mannhalter, PhD, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University Vienna, Währinger Gürtel 18–20, A-1097 Vienna, Austria. E-mail christine.mannhalter{at}meduniwien.ac.at
Background and Purpose— A Thr>Pro polymorphism at codon 715 in the coding region of the P-selectin gene has recently been described. Individuals carrying the Pro715 allele were reported to have a reduced risk of myocardial infarction. A possible association of this polymorphism with the risk of ischemic stroke is currently under discussion.
Methods— We investigated the prevalence of the 715 Thr>Pro polymorphism in 450 patients aged younger than 60 years with ischemic stroke or transient ischemic attack and in 450 controls without vascular disease matched for age and gender. We also investigated possible interactions of the polymorphism with other vascular risk factors, stroke severity and stroke etiology.
Results— The distribution of the two allelic variants of the 715Thr>Pro polymorphism did not differ significantly between patients and control subjects (78% versus 81% for Thr/Thr, 21% versus 18% for Thr/Pro and 1% versus 1% for Pro/Pro in patients and controls, respectively; adjusted odds ratio for carriers of the C allele: 1.0 [0.8 to 1.2; P=0.695]). We found no significant interaction of this polymorphism with vascular risk factors, stroke severity, or stroke etiology.
Conclusions— Our study supports results from previous investigation showing that the 715Thr>Pro polymorphism of the P-selectin gene was not associated with a risk or clinical characteristics of ischemic stroke.
Key Words: genetics • stroke
Related Articles:
Stroke 2007 38: 388-394.
Stroke 2007 38: 411-413.
Stroke 2007 38: 308-312.
Stroke 2007 38: 361-366.
Stroke 2007 38: 271-275.
Stroke 2007 38: 313-318.
Stroke 2007 38: 337-342.
Stroke 2007 38: 423-430.
Stroke 2007 38: 349-354.
PKC May Contribute to the Protective Effect of Hypothermia in a Rat Focal Cerebral Ischemia Model
Stroke 2007 38: 375-380.
Stroke 2007 38: 216-218.
Stroke 2007 38: 232-234.
Stroke 2007 38: 222-224.
Stroke 2007 38: 219-221.
Stroke 2007 38: 238-240.
Stroke 2007 38: 229-231.
Stroke 2007 38: 235-237.
Stroke 2007 38: 225-228.
Stroke 2007 38: 214-215.
Stroke 2007 38: 245-248.
This article has been cited by other articles:
 |
|
 |
|
  S. Beer, B. Aschbacher, D. Manoglou, E. Gamper, J. Kool, and J. Kesselring Robot-assisted gait training in multiple sclerosis: a pilot randomized trial Multiple Sclerosis, March 1, 2008; 14(2): 231 - 236. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Ay, L. V. Jungbauer, T. Sailer, T. Tengler, S. Koder, A. Kaider, S. Panzer, P. Quehenberger, I. Pabinger, and C. Mannhalter High Concentrations of Soluble P-Selectin Are Associated with Risk of Venous Thromboembolism and the P-Selectin Thr715 Variant Clin. Chem., July 1, 2007; 53(7): 1235 - 1243. [Abstract] [Full Text] [PDF]
|
|